Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Orbis Medicines ApS
APS
Active
Advertising protection
CVR 42715646
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
27 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Orbis Medicines ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MD
Morten Døssing
Chief Executive Officer
Chief Executive Officer
2025
Former (2)
SS
Søren Sylvester Skjærbæk
Management
Management
2021 – 2025
JC
João Carlos Ribas de Almeida
Management
Management
2021 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
AR
Alonso Ricardo Rodriguez
Board of Directors
Board of Directors
2024
GM
Goran Mikael Dolsten
Chairman
Chairman
2025
MB
Marco Boorsma
Board of Directors
Board of Directors
2025
ET
Edward Timothy Mathers
Board of Directors
Board of Directors
2024
SM
Søren Møller
Board of Directors
Board of Directors
2024
Former (1)
VC
Vanessa Carle
Board of Directors
Board of Directors
2024 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Novo Holdings A/S
Company
33.33–49.99%
33.33–49.99%
2024
Forbion Ventures Fund VI Coöperatief U.A.
Individual
33.33–49.99%
33.33–49.99%
2024
GF 2022 Global VC S.á r.l.
Individual
10–14.99%
10–14.99%
2024
Christian Heinis
Individual
5–9.99%
5–9.99%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Orbis Medicines ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network